Sep 30, 2021 07:14 PM IST
Under the partnership, T-Hub and Redberri will provide Indian and Chicago startups with business opportunities, market understanding and access to clients in Chicago and India, respectively.
- Aug 31, 2021 03:02 PM IST
The company has launched Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules USP, 5 mg/2.5 mg in the US market, Dr Reddy's Laboratories said in a regulatory filing.
- Aug 26, 2021 07:45 AM IST
Earlier this month, Google disclosed that it has designed its own processor chip to power its new Pixel 6 and Pixel 6 Pro high-end phones, ending its complete reliance on Qualcomm, which will still supply chips for the lower-priced Pixel 5A.
- Aug 05, 2021 10:32 AM IST
While India’s fundamentals are looking up, the big question to be asked is: what is happening to liquidity?
- Aug 04, 2021 10:49 AM IST
Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg.
- Jul 29, 2021 09:39 AM IST
While the immediate damage may be curtailed to some extent, what is the guarantee that China will not change the rules of the game again?
- May 24, 2021 05:23 PM IST
ICICI Direct has expanded its global investment facility to the United Kingdom, Japan, Hong Kong Germany and Singapore.
- Mar 14, 2021 11:29 AM IST
As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye.
- Jan 21, 2021 12:10 AM IST
Shares of the world's largest streaming service surged 14% to add more than $30 billion to its market capitalization, helping boost the broader tech-heavy Nasdaq 100 index .
- Aug 15, 2019 02:25 AM IST
All three major U.S. indexes were sharply lower as short- and long-dated Treasury yields inverted for the first time in 12 years, a potential signal of imminent recession.
- Jul 10, 2019 08:10 PM IST
The credit rating firm said it expects near doubling of research and development investments as Indian companies launch complex generics, specialty and biosimilar drugs
- Apr 09, 2019 08:21 AM IST
Investors would do well to look beyond the elections.
- Feb 06, 2019 10:27 AM IST
According to a letter written to the US Food and Drug Administration on Februray 4, the drug maker said the recall, which began in October 2018, was originally initiated due to a product complaint received for mislabelling.
- Jan 09, 2019 03:47 PM IST
"Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder) to the hospital level.
- Dec 27, 2018 12:41 PM IST
The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension, approved by the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a BSE filing.
- Dec 24, 2018 11:41 AM IST
The product is a therapeutic equivalent to generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules, the company said in a BSE filing.
- Nov 28, 2018 11:19 AM IST
Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton tablets, Dr Reddy's Laboratories said in a BSE filing.
- Oct 31, 2018 01:52 PM IST
The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equivalent of Eli Lilly and Company's Straterra, Dr Reddy's Laboratories said in a statement.
- Oct 22, 2018 04:36 PM IST
The company has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Mylan Pharmaceuticals Inc's Triamcinolone Acetonide Ointment, Lupin said in a statement.
- Apr 16, 2018 02:35 PM IST
They are weighing plans to rush shipments to American customers ahead of the increase, raise prices or find other markets. Some are looking at shipping goods through other countries to hide their Chinese origin.
- Jan 17, 2018 08:10 AM IST
GM forecast 2017 earnings per share at the high end of its previously forecast range of $6 to $6.50. The company expects earnings for 2018 to be roughly the same as in 2017. Analysts have predicted full-year 2017 earnings per share of $6.30, and $5.98 a share in 2018.
- Dec 04, 2017 04:15 PM IST
Mitessh Thakkar of mistesshthakkar.com said selling on rally would help and momentum would come in once we break below 10,100, then we could see severe declines.
- Sep 01, 2017 07:50 AM IST
A look at top cues from the domestic and international markets that could have a bearing on D-Street today.
- Aug 24, 2017 02:01 PM IST
According to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'class-I' classification.
- Aug 05, 2017 08:25 AM IST
The Dow Jones Industrial Average rose 0.3 percent to end at 22,092.81, an all-time high. The S&P 500 gained 0.19 percent to 2,476.83 and the Nasdaq Composite added 0.18 percent to 6,351.56.